Ohr Pharmaceutical - Articles and news items

emixustat

Ohr Pharmaceutical presents data from OHR-102 Phase II study in wet-AMD

Industry news / 7 May 2015 / Victoria White

Ohr Pharmaceutical presented the results from the Phase II IMPACT study evaluating OHR-102 combination therapy for the treatment of the wet-AMD at ARVO…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+